Related by context. All words. (Click for frequent words.) 74 medulloblastoma 70 DIPG 70 alveolar rhabdomyosarcoma 70 synovial sarcoma 69 Glioma 69 Wilms tumor 69 medulloblastomas 69 rhabdomyosarcoma 69 Hurler syndrome 68 embryonal rhabdomyosarcoma 68 astrocytoma 68 histologic subtype 67 pancreatic adenocarcinoma 67 ependymomas 67 Glioblastoma Multiforme 67 acute leukemias 67 leukemia ALL 66 Medulloblastoma 66 cranial radiation 66 Langerhans cell histiocytosis 66 neuroblastomas 66 GISTs 66 nasopharyngeal carcinoma 66 neuroblastoma tumor 66 Glioblastoma 66 pulmonary metastasis 66 paraganglioma 65 leiomyosarcoma 65 ductal adenocarcinoma 65 astrocytomas 65 acute lymphoblastic 65 chronic granulomatous disease 65 BRCA mutation carriers 65 breast carcinoma 65 ADPKD 65 osteosarcoma 65 histological subtype 65 neuroblastoma 65 Li Fraumeni syndrome 65 angiosarcoma 65 lymphoblastic leukemia 65 grade glioma 65 sporadic ALS 65 lung metastasis 65 thymoma 65 Lafora disease 64 SSc 64 pilocytic astrocytoma 64 carcinoid tumor 64 acute myeloid 64 juvenile myelomonocytic leukemia 64 grade cervical intraepithelial 64 gastrointestinal stromal tumor 64 lymphocytic leukemia 64 grade gliomas 64 gastric carcinoma 64 molecular abnormalities 64 Cholangiocarcinoma 64 Osteosarcoma 64 JMML 64 pulmonary metastases 64 Acute Myeloid Leukaemia AML 64 papillary renal cell carcinoma 64 renal carcinoma 64 squamous cell lung cancer 64 glioblastoma multiforme GBM 64 Glioblastoma multiforme GBM 64 cholangiocarcinoma 64 diffuse intrinsic pontine glioma 64 choriocarcinoma 64 MYCN amplification 64 gliomas 64 VCFS 64 operable breast cancer 64 carcinoid 64 Sjögren syndrome 64 NF1 64 teratoma 64 breast carcinomas 64 T1DM 64 malignant brain 64 MALT lymphoma 64 leukemia AML 64 nodal metastases 64 liver metastasis 64 myeloid leukemia 63 oligodendrogliomas 63 polycystic kidneys 63 Dravet syndrome 63 Burkitt lymphoma 63 Wilm Tumor 63 prostate cancer CaP 63 hepatoblastoma 63 demyelinating 63 mesotheliomas 63 cervical carcinoma 63 Glioblastoma Multiforme GBM 63 holoprosencephaly 63 invasive ductal 63 neuroblastoma tumors 63 Retinoblastoma 63 osteosarcomas 63 ANCA associated 63 Acute Lymphocytic Leukemia 63 dyskeratosis congenita 63 Chronic lymphocytic leukemia 63 metastatic cancer 63 HbF 63 acute promyelocytic leukemia 63 malignant lymphoma 63 breast cancer subtypes 63 basal cell carcinoma BCC 63 recurrent glioblastoma multiforme 63 Neuroblastoma 63 recurrent glioblastoma multiforme GBM 63 Hirschsprung disease 63 tumor recurrence 63 gastric adenocarcinoma 63 PARP inhibition 63 PCNSL 63 antibody mediated 63 Gliomas 63 medulloblastoma tumors 63 LQTS 63 HGPS 63 Rhabdomyosarcoma 63 lymphangioleiomyomatosis LAM 62 myelogenous leukemia 62 atypical hemolytic uremic syndrome 62 blastoma 62 Wilm tumor 62 Dr. Victor Velculescu 62 primitive neuroectodermal tumors 62 Leukemias 62 eosinophilic esophagitis 62 tuberous sclerosis complex 62 Acute Myelogenous Leukemia AML 62 hamartomas 62 CMV infection 62 renal cell carcinomas 62 metastatic lung cancer 62 Six3 62 epithelial tumors 62 fibrous dysplasia 62 epigenetic mechanisms 62 adenocarcinomas 62 Leber congenital amaurosis LCA 62 pilocytic astrocytomas 62 anaplastic 62 metachronous 62 nonsmall cell lung cancer 62 hepatic cirrhosis 62 leukoencephalopathy 62 prostate adenocarcinoma 62 essential thrombocythemia 62 cisplatin resistant 62 monogenic 62 RDEB 62 endometrioid 62 clinicopathological 62 node metastases 62 Wegener granulomatosis 62 Sanfilippo Syndrome 62 lung fibrosis 62 malignant fibrous histiocytoma 62 gastrointestinal malignancies 62 lymphoblastic lymphoma 62 choroidal melanoma 62 nonmelanoma skin cancers 62 cortical dysplasia 62 Niemann Pick disease 62 primitive neuroectodermal tumor 62 Ewing sarcoma bone 62 brain metastases 62 sarcomas 62 motor neuron degeneration 62 Fanconi anemia 62 uveal melanoma 62 EoE 62 pleural mesothelioma 62 transfusion syndrome 62 chromosome abnormality 62 glioblastoma 61 rhabdoid 61 autoimmune hemolytic anemia 61 CDH1 61 neoplasm 61 urothelial cancer 61 diabetes mellitus DM 61 HSCT 61 neurofibromatosis type 61 DNA methylation patterns 61 differentiated thyroid 61 HER2 overexpression 61 basal cell nevus syndrome 61 colorectal adenoma 61 bronchogenic carcinoma 61 cervical lymph nodes 61 Sanfilippo syndrome 61 metastatic malignant 61 NPHP 61 histiocytosis 61 juvenile idiopathic arthritis 61 neurofibroma 61 lobular carcinoma 61 Acute myeloid leukemia 61 extramedullary 61 ectodermal dysplasia 61 thyroid carcinoma 61 MGUS 61 Hepatocellular Carcinoma HCC 61 retinoblastoma 61 bronchopulmonary dysplasia 61 WT1 61 mtDNA mutations 61 childhood leukemias 61 acute lymphoid leukemia 61 Wilms tumors 61 cardiac dysfunction 61 colorectal tumor 61 systemic scleroderma 61 Acute Myeloid Leukaemia 61 autologous transplants 61 allogeneic HSCT 61 prognostic variables 61 squamous cell carcinoma SCC 61 CD# mAb 61 tumor histology 61 malignant lymphomas 61 Ewing sarcoma 61 carcinoid tumors 61 cerebral vasospasm 61 BCL#A 61 Wilms Tumor 61 meningiomas 61 systemic amyloidosis 61 paraneoplastic 61 metastatic lesions 61 Wegener Granulomatosis 61 sarcoma 61 #q#.# [001] 61 mucinous 61 graft dysfunction 61 acute myelogenous leukemia AML 61 gastric cancers 61 papillary carcinoma 61 urothelial carcinoma 61 euthymic patients 61 indolent lymphomas 61 spinal muscular atrophy SMA 61 malignant neoplasm 61 ductal breast cancer 61 pituitary adenomas 61 recurrent glioblastoma 61 microsatellite instability 61 osteopetrosis 61 smoldering myeloma 61 acute lymphoblastic leukemia 61 molecular subtypes 61 MELAS 61 precancerous cervical 61 myeloproliferative disorders 61 HNSCC 61 neurofibromatosis 61 FTLD 61 neovascularisation 61 hypophosphatasia 61 myotonic dystrophy 61 beta thalassemia 61 pseudotumor cerebri 61 HER2 positive metastatic breast 61 Glioblastoma multiforme 61 ABL1 61 chromosomal aberrations 61 brain tumors 61 Hutchinson Gilford progeria 61 stem glioma 61 peritoneal carcinomatosis 60 acute aortic dissection 60 mutated K ras 60 primary ciliary dyskinesia 60 HER2 positive cancers 60 ErbB2 positive 60 Chiari malformation 60 familial ALS 60 metastatic gastric 60 Endometrial cancer 60 airway hyperresponsiveness 60 somatic mutation 60 idiopathic pulmonary 60 bronchopulmonary dysplasia BPD 60 Acute Leukemia 60 Hurthle cell 60 biliary tract cancer 60 Leber Congenital Amaurosis LCA 60 chromosomal mutations 60 Philadelphia Chromosome Positive 60 MGd 60 Prox1 60 relapsed ALL 60 Eisenmenger syndrome 60 Metastases 60 CYT# potent vascular disrupting 60 somatic mutations 60 FSGS 60 atypical hyperplasia 60 sarcomatoid 60 squamous cell cancers 60 CMV infections 60 acute myeloid leukemia 60 hemophagocytic lymphohistiocytosis 60 atherosclerotic lesions 60 neurofibromas 60 colorectal cancer CRC 60 liver metastases 60 brainstem glioma 60 myeloproliferative disease 60 complement inhibitor eculizumab 60 situ LCIS 60 frontotemporal dementia 60 GIST tumors 60 HER2 expression 60 congenital diaphragmatic hernia 60 DiGeorge syndrome 60 endometrial cancers 60 nonmetastatic 60 pulmonary hypertension PH 60 lobular breast cancer 60 herpes simplex encephalitis 60 haematological cancers 60 cell acute lymphoblastic 60 cytogenetic abnormalities 60 nonalcoholic steatohepatitis NASH 60 beta1 integrin 60 de novo AML 60 FGFR2 gene 60 lysosomal storage disease 60 tumor subtype 60 imatinib therapy 60 ARVD 60 grade astrocytomas 60 cranial irradiation 60 Waldenstrom macroglobulinemia 60 peritoneal cancer 60 Gorlin syndrome 60 locoregional 60 recurrent miscarriage 60 tumoral 60 CIN2 + 60 PTPN# 60 inherited mutations 60 LHRH receptor positive 60 paragangliomas 60 congenital adrenal hyperplasia CAH 60 supratentorial 60 PNET 60 metastatic bladder 60 hepatocellular carcinomas 60 osteogenic sarcoma 60 myelodysplasia 60 sCJD 60 tumors 60 ruptured brain aneurysms 60 histologic findings 60 Chronic Lymphocytic Leukemia CLL 60 chronic periodontitis 60 hepatocellular carcinoma 60 mycosis fungoides 60 BMPR2 60 NF2 60 spastic diplegia 60 acute myeloid leukemia AML 60 lobular cancer 60 thoracic aortic disease 60 VUR 60 BRCA deficient 60 Anaplastic 60 metastatic tumors 60 gastrointestinal stromal tumor GIST 60 neoplastic lesions 60 Meningiomas 60 GSTP1 60 ovarian carcinoma 60 histopathologic examination 60 T1D 60 NMIBC 60 carcinoid cancer 60 gastrointestinal stromal tumors GISTs 60 Hodgkin lymphoma HL 60 EBV infection 60 de novo mutations 60 membranous nephropathy 60 missense mutations 60 invasive lobular carcinoma 60 distant metastasis 60 enterocolitis 60 osteochondromas 60 glioblastoma tumors 60 prognostic indicator 60 Prognostic factors 60 Gleevec resistant 60 nodal metastasis 60 Li Fraumeni 60 Cowden syndrome 60 benign polyps 60 leukaemias 60 K ras mutations 60 invasive lobular 60 #F FDG PET 60 premalignant lesions 60 diffuse pontine glioma 60 arterial calcification 60 etiologic 60 autosomal dominant 60 adenoid cystic carcinoma 60 Angelman syndrome 60 renal scarring 59 aneuploid cells 59 ovarian tumors 59 Glioblastomas 59 lymphocytic 59 PAOD 59 Papillary 59 pheochromocytoma 59 Hashimoto thyroiditis 59 electrophysiologic 59 epithelial ovarian cancer 59 CIN3 59 immunohistochemical 59 chronic myeloid 59 osteochondroma 59 myeloproliferative diseases 59 LVNC 59 mitochondrial disorders 59 neuronal dysfunction 59 serous ovarian cancer 59 Severe Primary IGFD 59 LRRK2 gene 59 Leber congenital amaurosis 59 Kufs disease 59 de ath 59 breast cancer metastasis 59 haematopoietic 59 preoperative chemotherapy 59 leukaemic stem cells 59 resectable pancreatic cancer 59 papillary RCC 59 Ewings Sarcoma 59 Mantle Cell Lymphoma 59 gynecologic malignancy 59 severe aplastic anemia 59 Dysplasia 59 Acute Myelogenous Leukemia 59 hamartoma 59 Diffuse Intrinsic Pontine Glioma 59 idiopathic pulmonary arterial hypertension 59 Estrogen Receptor 59 demyelination 59 aneuploidies 59 von Willebrand 59 type 1diabetes 59 desmoplastic 59 HNPCC 59 interrupted aortic arch 59 nonhereditary 59 malignant pancreatic 59 malignant pleural mesothelioma 59 chromosomal anomalies 59 intractable epilepsy 59 APOL1 59 Astrocytoma 59 Synovial sarcoma 59 Leydig cell 59 adrenal tumors 59 lymphoproliferative disorder 59 SMN protein 59 premalignant 59 thyroid nodules 59 esophageal carcinoma 59 Anthracycline 59 GRP# 59 axillary dissection 59 epilepsies 59 KRAS wild 59 Adjuvant chemotherapy 59 Malignant Melanoma 59 p# mutations 59 chromosomal defect 59 CP CPPS 59 depsipeptide 59 myeloproliferative neoplasms 59 dyskinetic 59 fronto temporal dementia 59 Becker muscular dystrophy 59 Epstein Barr Virus EBV 59 chemoresistance 59 diagnostic biomarker 59 Metastatic 59 prostate cancer PCa 59 glioblastoma GBM 59 Cockayne syndrome 59 miRNA expression 59 squamous carcinoma 59 Peutz Jeghers syndrome 59 esophageal squamous cell carcinoma 59 cystic kidney 59 diffuse gastric 59 Acute Lymphoblastic Leukemia 59 congenita 59 hematologic malignancy 59 oral squamous cell 59 TTF Therapy 59 mitochondrial dysfunction 59 thoracic aortic aneurysm 59 Lennox Gastaut Syndrome 59 Paroxysmal Nocturnal Hemoglobinuria PNH 59 colorectal liver metastases 59 Wiskott Aldrich syndrome 59 subependymal giant cell 59 kidney urologic 59 metaplasia 59 hypereosinophilic syndrome 59 BRAF gene 59 pancreatic carcinoma 59 gene MECP2 59 bladder cancers 59 BRAF V#E 59 karyotypes 59 lymphatic tissue 59 chronic GVHD 59 von Hippel Lindau 59 renal tumors 59 hepatorenal syndrome 59 monocytic 59 MECP2 gene 59 cancer mCRC 59 precursor lesions 59 hepatocellular carcinoma HCC 59 epithelial ovarian 59 Moyamoya disease 59 TTTS 59 familial pancreatic cancer 59 epithelioid 59 invasive candidiasis 59 B Cell Lymphoma 59 persistent pulmonary hypertension 59 oesophageal adenocarcinoma 59 subarachnoid haemorrhage 59 flavopiridol 59 neoplastic 59 neuroendocrine tumors 59 PTEN gene 59 Acute Lymphoblastic Leukaemia 59 Neurofibromatosis type 59 lymph node metastasis 59 Follicular Lymphoma 59 B7 H3 59 GH deficiency 59 CHDs 59 atypical rhabdoid tumor 59 proto oncogene 59 IKZF1 59 TET2 59 adenoma 59 murine models 59 lung tumors 59 bladder carcinoma 59 superficial bladder cancer 59 Myelodysplastic syndrome 59 perioperative morbidity 59 immunodeficiencies 59 renovascular hypertension 59 seminoma 59 cutaneous melanoma 59 malignant transformation 59 immunocompetent 59 gene amplification 59 Ewings sarcoma 59 autosomal dominant polycystic kidney 59 Duchenne Muscular Dystrophy DMD 59 trophoblast cells 59 aneuploidy 59 metastatic renal 59 IDH1 mutation 59 allogeneic bone marrow 59 hematopoietic cancers 59 ADAMTS# 59 allogeneic transplant 59 chromosomal instability 59 pT2 59 cervical intraepithelial neoplasia 59 nasopharyngeal carcinoma NPC 59 prostate carcinoma 59 postoperative complication 59 heterotaxy 59 neurodevelopmental disorder 59 Lymphocytic 59 follicular lymphoma FL 59 Cell Lymphoma 59 thymectomy 59 underwent resection 59 KRAS oncogene 59 Haptoglobin 59 distant metastases 59 PCa 59 childhood acute lymphoblastic 59 seminomas 59 multidrug resistance 59 microRNA expression 59 gastrointestinal GI cancers 59 vestibular schwannomas 59 PTLD 58 leukemic stem cells 58 Subgroup analysis 58 colorectal carcinoma 58 malignant prostate 58 pathologic diagnosis 58 liposarcoma 58 Epstein Barr Virus 58 GBM tumors 58 neurodegenerative disorder 58 pre cancerous lesion 58 neoplasias 58 non metastatic osteosarcoma 58 thrombotic complications 58 vWD 58 nodular melanoma 58 Circulating tumor cells 58 Friedreich ataxia 58 genetic syndromes 58 generalized epilepsy 58 pancreatic endocrine 58 thrombophilia 58 NKX2 58 intestinal polyps 58 chromosomal imbalance 58 Epstein Barr virus EBV 58 Immunohistochemical analysis 58 unresectable tumors 58 endocrine tumors 58 stratifying patients 58 bone marrow mesenchymal stem 58 juvenile idiopathic arthritis JIA 58 colorectal adenocarcinoma 58 contralateral breast 58 soft tissue sarcomas 58 glomerulonephritis 58 tumorigenicity 58 pleomorphic 58 JAK mutations 58 metastatic lymph nodes 58 Kabuki syndrome 58 portal vein thrombosis 58 1 diabetes T1D 58 brain tumor glioblastoma multiforme 58 prognostic significance 58 histological subtypes 58 polymorphic ventricular tachycardia 58 disc degeneration 58 precancerous condition 58 Sentinel node biopsy 58 chlamydial infection 58 Legg Calvé Perthes disease 58 spinocerebellar ataxia 58 ImmuKnow 58 mosaicism 58 thiopurine 58 fulminant hepatic failure 58 Brugada Syndrome 58 normal karyotype 58 neuro endocrine 58 C1q 58 epigenetic changes 58 grade cervical dysplasia 58 cervical lesions 58 infective endocarditis 58 postoperative delirium 58 brain malformation 58 neuro degenerative disorder 58 intraventricular hemorrhage 58 multisystem disease 58 metastatic ovarian cancer 58 poorer prognosis 58 Myocarditis 58 Spinal Muscular Atrophy SMA 58 fibrotic disease 58 dysplasia 58 resected pancreatic cancer 58 Myelodysplastic Syndrome 58 fibrosarcoma 58 Cryptococcus neoformans 58 remyelination 58 bladder tumors 58 ptau 58 mutational status 58 malignant phenotype 58 tumor 58 adrenalectomy 58 pretransplant 58 Aortic stenosis 58 Brugada syndrome 58 leiomyomas 58 Ewing Sarcoma 58 papillary thyroid cancer 58 preserved ejection fraction 58 Acute lymphoblastic leukemia 58 molar pregnancy 58 nonsense mutations 58 SCCHN 58 #q# deletion syndrome 58 radiochemotherapy 58 Nephrotic Syndrome 58 neuromotor 58 orthotopic model 58 Squamous 58 myeloproliferative 58 neuropsychiatric disorder 58 percutaneous biopsy 58 papillary thyroid carcinoma 58 uterine tumors 58 leiomyoma 58 CIN2 58 kidney allograft 58 anti angiogenic drugs 58 spinal metastases 58 Fanconi Anemia 58 Hurler Syndrome 58 myeloproliferative disorder 58 ER CHOP 58 SRBD 58 ovarian lung 58 pancreatectomy 58 tumor subtypes 58 prognostic biomarker 58 enteroviral infection 58 Chronic Myeloid Leukemia 58 intraepithelial neoplasia 58 clinico pathological 58 cutaneous squamous cell carcinoma 58 microchimerism 58 thymic carcinoma 58 acute GvHD 58 Spinal muscular atrophy 58 aplasia 58 Non Hodgkins lymphoma 58 carcinomatosis 58 ELACYT 58 advanced adenoma 58 carcinoma 58 mastocytosis 58 cytogenic 58 heavily pretreated 58 Alagille syndrome 58 Joubert syndrome 58 vesicoureteral reflux 58 Wilms Tumour 58 immunopathology 58 infantile spasms 58 haematopoietic stem cell 58 trans retinoic acid 58 chronic eosinophilic leukemia 58 carotid stenosis 58 parathyroid 58 p# mutation 58 imatinib resistance 58 biochemical recurrence 58 invasive carcinoma 58 testicular tumors 58 BRAF V#E mutation 58 invasive aspergillosis 58 lung adenocarcinomas 58 infarcts 58 IgA deficiency 58 metastatic neuroendocrine tumors 58 lymphomas leukemias 58 LRP5 58 neurodevelopmental disability 58 trophoblastic 58 lymphomas 58 leukemias lymphomas 58 PSADT 58 lysosomal storage diseases 58 hemodialysis patients 58 Basal cell 58 HLA B# 58 malignant growths 58 HER2 positivity 58 MSH2 58 glioblastomas 58 MLH1 58 Doxil ® 58 MMP inhibitor 58 proband 58 chemosensitivity 58 endometrial hyperplasia 58 TMEM#B 58 anaplastic astrocytoma 58 KRAS mutation 58 neoplasia 58 BCR ABL mutations 58 cytomegalovirus infection 58 Adenocarcinoma 58 Metastatic breast cancer 58 eosinophilic asthma 58 NAFLD 58 brachial plexus palsy 58 ductal carcinomas 58 epigenetic modification 58 chromosome deletion 58 microvascular dysfunction 58 AA Amyloidosis 58 chemoradiation 58 #q#.# deletion syndrome 58 clinically localized prostate 58 Krabbe Disease 58 Neurofibromatosis Type 58 pediatric neuroblastoma 58 ventricular dysfunction 58 lymphangiogenesis 58 allograft rejection 58 haematologic 58 medically inoperable 58 herpesviruses 58 gastric cardia 58 hematological malignancy 58 prognostic indicators 58 Pleural mesothelioma 58 Burkitt Lymphoma 58 degenerative neurological diseases 58 meningioma 58 candidemia 58 myotonic muscular dystrophy 58 hypoperfusion 58 chromosomal rearrangement 58 papillary 58 autosomal dominant inheritance 58 chemoradiotherapy 58 fibroma 58 mammary cells 58 locoregional recurrence 58 ERK signaling 58 arteriovenous malformations 58 Medullary thyroid cancer 58 bile duct cancers 58 medulloblastoma malignant brain tumor 57 neoplasms 57 E cadherin expression 57 glial tumors 57 ovarian pancreatic 57 neurodevelopmental impairment 57 syngeneic 57 cerebri 57 genetic determinants 57 HLHS 57 axillary node 57 motor neurone 57 Juvenile Idiopathic Arthritis 57 generalized seizures 57 Synovial Sarcoma 57 Crouzon Syndrome 57 Chronic pancreatitis 57 RRM1 57 infantile hemangioma 57 prognostic factor 57 autosomal recessive 57 PITX2 57 TOP2A 57 congenital disorders 57 T1c 57 CTEPH 57 endoscopic resection 57 neurocognitive impairment 57 idiopathic scoliosis 57 HGPIN 57 TTR amyloidosis 57 pCR 57 chromosome #q#.# [001] 57 prognostic markers 57 pneumococcal meningitis 57 GBMs 57 immunohistochemical staining 57 urolithiasis 57 idiopathic PAH 57 ccRCC 57 pancreatic fistula 57 transgene expression 57 anti angiogenic therapy 57 lymphoid 57 osteosarcoma bone 57 leukemic cells 57 Genetic variants 57 extracranial 57 transplanted bone marrow 57 progressive neurodegenerative disorder 57 Lung transplantation 57 ischemic cardiomyopathy 57 ischemic mitral regurgitation 57 histologies 57 chromosome abnormalities 57 cellularity 57 Idiopathic pulmonary fibrosis 57 HER2 amplified 57 multivariate Cox 57 lymphovascular invasion 57 Duchenne muscular dystrophy DMD 57 colon carcinoma 57 oncogenesis 57 mammographic density 57 hyperplastic 57 osteoporotic vertebral fractures 57 severe oral mucositis 57 lysosomal diseases 57 GRN# 57 allogeneic stem cell 57 hypermethylated 57 promoter hypermethylation 57 microglial 57 pretreatment serum 57 telomere lengths 57 acute leukemia 57 hematologic disorders 57 FDG uptake 57 LRRK2 mutation 57 basal cell carcinomas 57 pancreatic ductal adenocarcinoma 57 multiforme 57 Ebstein anomaly 57 LHON 57 PTEN protein 57 bleomycin 57 IGFD 57 acute myelogenous 57 hereditary breast cancer 57 advanced adenomas 57 #q# deletion 57 hyperinsulinism 57 SUVmax 57 arteriography 57 FGFR1 57 dysbindin 57 LV dysfunction 57 ductal cancer 57 transitional cell carcinoma 57 histologic subtypes 57 chemoresistant 57 chronic myelogenous leukemia CML 57 anterior uveitis 57 IPAH 57 narcolepsy cataplexy 57 repolarization 57 RET PTC rearrangements 57 Malignant glioma 57 T#I [002] 57 inherited neurological disorder 57 thyroglobulin 57 clinicopathologic 57 perfusion abnormalities 57 stage IIIA 57 Chronic lymphocytic leukemia CLL 57 Renal Cell Carcinoma RCC 57 NSCLC tumors 57 penetrance 57 IDH mutations 57 malignant gliomas 57 standard chemotherapy regimens 57 hyperparathyroidism 57 Lymph node 57 TACE 57 cardiac allograft vasculopathy 57 gene rearrangements 57 malignancy 57 Oesophageal cancer 57 post thrombotic syndrome 57 cyclin E 57 graft occlusion 57 proliferative retinopathy 57 malignancies 57 monozygotic twin 57 Alzheimer Disease AD 57 lymphoma 57 Malignant mesothelioma 57 clinicopathological features 57 metastases 57 renal biopsy 57 angiogenesis inhibition 57 Vidaza ® 57 Henoch purpura 57 Carcinoma 57 TRAIL induced apoptosis 57 invasive ductal breast cancer 57 histologic 57 Morquio syndrome 57 postoperative pathology 57 Retinopathy 57 schwannoma 57 PPCM 57 post transplant lymphoproliferative 57 acute promyelocytic leukemia APL 57 myelomeningocele